{"id":20127,"date":"2011-09-24T05:42:35","date_gmt":"2011-09-24T09:42:35","guid":{"rendered":"http:\/\/asweetlife.org\/?p=20127"},"modified":"2015-12-30T04:20:19","modified_gmt":"2015-12-30T09:20:19","slug":"eu-finds-novo-nordisks-detemir-safe-for-children-aged-2-5","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=20127","title":{"rendered":"EU Finds Novo Nordisk&#8217;s Detemir Safe for Children Aged 2-5"},"content":{"rendered":"<div dir=\"ltr\">\n<div style=\"text-align: justify;\"><a href=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/09\/NovoNordiskLogo1.png\" rel=\"mfp\"><img decoding=\"async\" class=\"alignleft size-full wp-image-20129 lazyload\" title=\"NovoNordiskLogo\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/09\/NovoNordiskLogo1.png\" alt=\"\" width=\"151\" height=\"112\" \/><\/a>The European Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion on the extended use of Novo Nordisk\u2019s basal insulin analogue, insulin detemir, in children with type 1 diabetes, aged two to five years. The CHMP decision was made after the review of data\u00a0demonstrating that insulin detemir is an equally efficacious treatment option for two to five-year-old children with type 1 diabetes, compared with NPH1,2.<\/div>\n<div style=\"text-align: justify;\">\n<div>\u00a0<\/div>\n<div>The pre-specified and stratified subgroup data show that children aged two to five years treated with insulin detemir plus a fast-acting insulin analogue, insulin aspart, experienced a lower rate of all-day and nocturnal hypoglycaemia compared to those taking human basal insulin (neutral protamine Hagedorn insulin) and insulin aspart (24-hour: 50.6 vs 78.3 episodes per patient year; nocturnal hypoglycemia: 8.0 vs 17.4 episodes per patient year).<\/div>\n<div>\u00a0<\/div>\n<div>Because\u00a0the study was conducted on a small number of patients no statistical analyses have been conducted, but the hypoglycemic risk differences follow the same patterns that were revealed in the overall cohort where differences proved to be statistically significant. No patients treated with insulin detemir had a severe hypoglycemic episode, whereas there were six reported episodes in three patients treated with human basal insulin.<\/div>\n<div>Novo Nordisk anticipates that the European Commission will extend the marketing authorization within the coming months, which will make insulin detemir the only basal insulin analogue for the use in this young patient group supported by results from a randomized clinical trial. \u00a0 \u00a0 \u00a0<\/div>\n<\/div>\n<div style=\"text-align: justify;\">\u00a0<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The European Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion on the extended use of Novo Nordisk\u2019s basal insulin analogue, insulin detemir, in children with type 1 diabetes, aged two to five years. The CHMP decision was made after the review of data demonstrating that insulin detemir&#8230;<\/p>\n","protected":false},"author":131,"featured_media":20129,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1441,1430],"tags":[20,1127],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.9 (Yoast SEO v22.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>EU Finds Novo Nordisk&#039;s Detemir Safe for Children Aged 2-5<\/title>\n<meta name=\"description\" content=\"The CHMP adopted a positive opinion on the extended use of Novo Nordisk\u2019s basal insulin detemir in children with type 1 diabetes, aged 2 to 5 years.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=20127\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ASweetLife Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=20127\",\"url\":\"https:\/\/asweetlife.org\/?p=20127\",\"name\":\"EU Finds Novo Nordisk's Detemir Safe for Children Aged 2-5\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=20127#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=20127#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/09\/NovoNordiskLogo1.png\",\"datePublished\":\"2011-09-24T09:42:35+00:00\",\"dateModified\":\"2015-12-30T09:20:19+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\"},\"description\":\"The CHMP adopted a positive opinion on the extended use of Novo Nordisk\u2019s basal insulin detemir in children with type 1 diabetes, aged 2 to 5 years.\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=20127#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=20127\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=20127#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/09\/NovoNordiskLogo1.png\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/09\/NovoNordiskLogo1.png\",\"width\":215,\"height\":160,\"caption\":\"Novo Nordisk\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=20127#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU Finds Novo Nordisk&#8217;s Detemir Safe for Children Aged 2-5\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\",\"name\":\"ASweetLife Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"caption\":\"ASweetLife Team\"},\"url\":\"https:\/\/asweetlife.org\/?author=131\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"EU Finds Novo Nordisk's Detemir Safe for Children Aged 2-5","description":"The CHMP adopted a positive opinion on the extended use of Novo Nordisk\u2019s basal insulin detemir in children with type 1 diabetes, aged 2 to 5 years.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=20127","twitter_misc":{"Written by":"ASweetLife Team","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=20127","url":"https:\/\/asweetlife.org\/?p=20127","name":"EU Finds Novo Nordisk's Detemir Safe for Children Aged 2-5","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=20127#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=20127#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/09\/NovoNordiskLogo1.png","datePublished":"2011-09-24T09:42:35+00:00","dateModified":"2015-12-30T09:20:19+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585"},"description":"The CHMP adopted a positive opinion on the extended use of Novo Nordisk\u2019s basal insulin detemir in children with type 1 diabetes, aged 2 to 5 years.","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=20127#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=20127"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=20127#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/09\/NovoNordiskLogo1.png","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/09\/NovoNordiskLogo1.png","width":215,"height":160,"caption":"Novo Nordisk"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=20127#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"EU Finds Novo Nordisk&#8217;s Detemir Safe for Children Aged 2-5"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585","name":"ASweetLife Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","caption":"ASweetLife Team"},"url":"https:\/\/asweetlife.org\/?author=131"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/20127"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20127"}],"version-history":[{"count":0,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/20127\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/20129"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20127"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}